In an effort to bolster its post-market surveillance of medical devices, the FDA will focus on five projects that include creating a planning board for the post-market surveillance system and finalizing rules for a unique device identification system. In addition, the FDA will encourage the creation of national and international registries for certain products, modernize the reporting and analysis of adverse events and develop and implement new methods.

Full Story:

Related Summaries